drugset / Trial / NCT02915666
A Clinical Trial of Patients With Melanoma
NaSingle-groupOpen-labelTreatment
Summary
This study is being done to find out if the combination of dabrafenib, trametinib and digoxin will lessen the side effects that you may experience and to measure your response and duration of response to the combination of drugs.
Timeline
- Start
- 2016-10
- Primary completion
- 2017-07-17
- Completion
- 2017-07-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dabrafenib | Small molecule | 150 mg | Oral |
| Subject | Digoxin | Other / unclassified | 0.25 mg | Oral |
| Subject | Trametinib | Small molecule | 2 mg | Oral |